Woburn, MA, United States of America

Subhashchandra Naik


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Subhashchandra Naik in Protein Formulations

Introduction: Subhashchandra Naik, an inventor based in Woburn, MA, has made significant strides in the field of protein formulations. With a focus on improving the delivery of concentrated protein solutions, Naik’s innovation addresses critical challenges in the pharmaceutical and biotechnology industries.

Latest Patents: Naik holds a patent for "Viscosity-reducing compounds for protein formulations." This invention encompasses formulations and methods that facilitate the delivery of concentrated protein solutions. The innovative methods developed by Naik result in a lower viscosity liquid protein formulation or a higher concentration of therapeutic or nontherapeutic proteins compared to traditional solutions. Moreover, his methods enhance the stability of liquid protein formulations, showcasing his commitment to advancing biopharmaceutical technologies.

Career Highlights: Currently, Subhashchandra Naik is affiliated with Comera Life Sciences, Inc., where he applies his expertise in developing transformative protein solutions. His contributions have not only increased the effectiveness of protein treatments but also paved the way for new methodologies in formulating medicinal compounds.

Collaborations: Throughout his career, Naik has collaborated with talented professionals, including his coworkers Philip Wuthrich and Robert P Mahoney. These collaborations have further enriched his innovative endeavors and have contributed to the success of the projects he undertakes.

Conclusion: Subhashchandra Naik exemplifies the spirit of innovation in the biotechnology field. His patent for viscosity-reducing compounds significantly enhances the quality and delivery of protein formulations. As he continues to work with Comera Life Sciences, Inc., Naik's contributions are poised to have a lasting impact on the industry and improve therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…